222 related articles for article (PubMed ID: 33133025)
1. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
Zhao B
Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
[TBL] [Abstract][Full Text] [Related]
2. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
3. Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?
Zhao B
Crit Rev Immunol; 2018; 38(4):253-261. PubMed ID: 30806242
[TBL] [Abstract][Full Text] [Related]
4. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
5. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.
Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B
J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696
[TBL] [Abstract][Full Text] [Related]
6. Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.
Ng C; Qin Y; Xia Y; Hu X; Zhao B
J Immunol; 2023 Nov; 211(9):1340-1347. PubMed ID: 37756541
[TBL] [Abstract][Full Text] [Related]
7. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
Inoue K; Hu X; Zhao B
FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
[TBL] [Abstract][Full Text] [Related]
8. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
9. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.
Kim Y; Hayashi M; Ono T; Yoda T; Takayanagi H; Nakashima T
Mod Rheumatol; 2020 Jan; 30(1):85-92. PubMed ID: 30486712
[No Abstract] [Full Text] [Related]
13. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
14. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
15. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
16. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.
Xia Y; Inoue K; Du Y; Baker SJ; Reddy EP; Greenblatt MB; Zhao B
Nat Commun; 2022 Jul; 13(1):3920. PubMed ID: 35798734
[TBL] [Abstract][Full Text] [Related]
17. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
[TBL] [Abstract][Full Text] [Related]
19. New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis.
Papadaki M; Rinotas V; Violitzi F; Thireou T; Panayotou G; Samiotaki M; Douni E
Front Immunol; 2019; 10():97. PubMed ID: 30804932
[TBL] [Abstract][Full Text] [Related]
20. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
